XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 25.81

+1.1%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cacaito who wrote (15889)	7/17/2002 5:33:28 AM
From: Lance Bredvold	of 17367

OK, looked at DNA's April 9 first quarter report and found 3 paragraphs on xanelim and a statement that BLA is apt to be delayed beyond summer 2002. The word contingencies did not show up there, but I'll go look another time. Also a slightly earlier report of xanelim manufacturing difficulties between XOMA and DNA. It's the first time I've looked at Genentechs view of Xanelim and worthwhile no doubt. You are correct in assuming that I was lost with all your talk of contingencies and now understand that item better. L.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next